Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Apr 6, 2022; 10(10): 3078-3087
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3078
Table 1 Baseline characteristic profiles and clinical outcomes in patient with extrahepatic cholangiocarcinoma
Baseline characteristics
Age (yr, ≤ 70/ > 70)57/ 59
Gender (female/male)49/ 67
Comorbidity (-/+)75/ 41
Location of tumor (distal CBD/proximal CBD/CHD or Klatskin tumor)51/43/22
Preoperative drainage
None5
Endoscopic bile drainage87
PTBD24
Resection margin
Negative72
LGD positive19
HGD/CIS positive25
T stage (T1/2/3/4)42/ 49/ 25/ 0
N stage (0/1)82/ 34
Perineural invasion (-/+)41/ 75
Lymphatic invasion (-/+)81/ 35
Differentiation (well/ moderate/ poor)18/ 72/ 26
CA 19-9 (≤ 37/> 37)44 / 72
Op method
BDR24
PPPD or Whipple operation70
BDR + hepatectomy19
BDR+ PPPD or Whipple + hepatectomy3
Adjuvant therapy (-/+)70 / 46
Clinical outcomes
Recurrence rate63 (54.3)
Time from operation to recurrence13 mo
Op related death10 (8.6)
≤ 70 years old: 2/ 57 (3.5)
> 70 years old: 8/ 59 (13.6)
Mortality77 (66.4)
Cancer related mortality65/ 77(84.4)
Overall survival (mean)44.2 ± 3.43 mo